Meningococcal Group B Vaccine for gonorrhea

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Sep 2019: Trial registered, NCT04094883
  2. 9 Oct 2019: Trial started, NCT04094883

The trials

NCT04094883: Study to Assess Gonorrhoeae Immune Responses Induced by a N. Meningitidis Vaccine

State
Completed
Phase
Phase 4
People
11 taking part
Started
9 Oct 2019
Primary completion
1 Sep 2020
Arms
4CMenB Vaccine
Results
Posted on the registry
  1. 19 Sep 2019: Trial registered
  2. 9 Oct 2019: Trial started
  3. 1 Sep 2020: Trial completed
  4. 15 Jul 2021: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.